Ultime notizie per Medifast (NYSE:MED) Azioni

Medifast

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Medifast Inc

MediBloc

Medacoin

Medaro Mining Corp

MEDARO MINING CORP by Medaro Mining Corp.

MEDICAL IMAGING CORP by Medical Imaging Corp.

Medical Imaging Corp

Medies

Medacta Group SA

Dazed Inc

Harbor ETF Trust Harbor Health Care ETF

Media Network - United States Dollar

MEDIPHARM LABS CORP by Medipharm Labs Corporation

MediPharm Labs Corp

Medios AG

Medpace Holdings Inc

MEDPACE HOLDINGS ORD

MEDIATECHNICS CORP by MediaTechnics Corp.

MediaTechnics Corp

Medivolve Inc

Horizon Kinetics Medical ETF

MEDEXUS PHARMS INC by Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc

DA Davidson analyst Linda Bolton Weiser upgrades Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) from Underperform to Neutral and raises the price target from $16.5 to $17.

News

Upgrades

Price Target

Analyst Ratings

DA Davidson Upgrades Medifast to Neutral, Raises Price Target to $17

Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) is looking for Q4 GAAP EPS of $0.10-0.65 vs $(0.18) analyst estimate. sees sales of $100.000 million-120.000 million vs $129.95 million estimate.

Guidance

Medifast Sees Q4 GAAP EPS $0.10-0.65 vs $(0.18) Est; Sees Sales $100.000M-120.000M vs $129.95M Est

Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $(0.28) by 225 percent. The company reported quarterly sales of $140.163 million which beat the analyst consensus estimate of $134.150 million by 4.48 percent. This is a 40.58 percent decrease over sales of $235.869 million the same period last year.

Earnings

Earnings Beats

Medifast Q3 2024 Adj. EPS $0.35 Beats $(0.28) Estimate, Sales $140.163M Beat $134.150M Estimate

Medifast Sees Q3 EPS $(0.70)-$(0.05) vs $(0.52) Est., Revenue $125M-$145M vs $161.8M Est.

Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.39 by 135.9 percent. The company reported quarterly sales of $168.558 million which missed the analyst consensus estimate of $174.050 million by 3.16 percent. This is a 43.09 percent decrease over sales of $296.188 million the same period last year.

Earnings Misses

Medifast Q2 2024 Adj. EPS $0.92 Beats $0.39 Estimate, Sales $168.558M Miss $174.050M Estimate

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) with a Underperform and maintains $17.5 price target.

DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target

WIIM

MEDIFAST shares are trading lower after DA Davidson downgraded the stock from Neutral to Underperform and lowered its price target from $25 to $17.5.

DA Davidson analyst Linda Bolton Weiser downgrades Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) from Neutral to Underperform and lowers the price target from $25 to $17.5.

Downgrades

DA Davidson Downgrades Medifast to Underperform, Lowers Price Target to $17.5

Medifast's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) short percent of float has risen 3.9% since its last report. The company recently reported that it has 3.24 million shares sold short, which is 45.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Medifast Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1717169418_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medifast has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Medifast's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Medifast's peer group average for short interest as a percentage of float is 5.01%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Medifast's Recent Short Interest

Medifast's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) short percent of float has risen 11.91% since its last report. The company recently reported that it has 2.99 million shares sold short, which is 41.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Medifast Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715610621_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medifast has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Medifast's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Medifast's peer group average for short interest as a percentage of float is 4.98%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(MED) - Analyzing Medifast's Short Interest

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the &lt;a href=&#8221;https://www.benzinga.com/topic/rsi&#8221;> <a href="https://www.benzinga.com/topic/rsi">RSI is below 30&lt;</a>/a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>)
<ul>
<li>On April 29, Medifast reported mixed first-quarter financial results. &#8220;Fast paced medical innovation is providing greater access to medical weight loss solutions than ever before. We are transforming our OPTAVIA offer to include comprehensive support for consumers who wish to use GLP-1 medical weight loss solutions on their individual journeys to sustainable healthy lifestyles, Chairman &amp; Chief Executive Officer. The company's stock fell around 21% over the past five days and has a <a href="https://www.benzinga.com/quote/MED">52-week low of $25.92</a>.</li>
<li>RSI Value: 28.64</li>
<li>MED Price Action: Shares of Medifast fell 4.3% to close at $26.36 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Safety Shot, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOT#NASDAQ">SHOT</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On April 9, Safety Shot said the Nelk Boys have joined forces with Safety Shot as brand ambassadors. The company's stock fell around 35% over the past month. It <a href="https://www.benzinga.com/quote/SHOT">has a 52-week lo</a>w of $0.3050.</li>
<li>RSI Value: 29.61</li>
<li>SHOT Price Action: Shares of Safety Shot fell 9.2% to close at $1.39 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>)</h3>
<ul>
<li>On April 30, Molson Coors Beverage reported first-quarter FY24 sales growth of 10.7% year-on-year to $2.60 billion, beating the analyst consensus estimate of $2.50 billion. "Strong America's volume and favorable net pricing across both business units resulted in double-digit top-line growth while volume leverage and ongoing cost savings drove meaningful margin expansion in the quarter," said CFO Tracey Joubert. The company's shares fell around 11% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/TAP">low of $55.67</a>.</li>
<li>RSI Value: 22.34</li>
<li>TAP Price Action: Shares of Molson Coors Beverage fell 0.3% to close at $57.08 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Australian Oilseeds Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOT#NASDAQ">COOT</a>)</h3>
<ul>
<li>On April 25, Australian Oilseeds secured contracts with Woolworths and Costco for non-GMO cold-pressed oils. The company's shares lost around 7% over the past five days. The company's 52-week low is $1.14.</li>
<li>RSI Value: 28.98</li>
<li>COOT Price Action: Shares of Australian Oilseeds Holdings rose 1.1% to close at $1.3350 on Wednesday.</li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

COOT

SHOT

Top 4 Defensive Stocks You'll Regret Missing This Quarter

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 1% on Tuesday.
The Dow traded down 0.99% to 38,005.55 while the NASDAQ fell 1.09% to 15,808.29. The S&amp;P 500 also fell, dropping, 0.85% to 5,072.88.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38489087/jim-cramer-likes-palantir-recommends-pioneer-natural-resources-i-want-you-to-ka-ching-ka-ching">Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: &#8216;I Want You To Ka-Ching, Ka-Ching&#8217;</a>
Leading and Lagging Sectors Health care shares rose by 0.1% on Tuesday.
In trading on Tuesday, energy shares fell by 2.1%.
Top Headline
3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) reported better-than-expected first-quarter 2024 results.
The company reported net sales of $8.00 billion, a slight decline of 0.35%Y/Y. Adjusted net sales totaled $7.72 billion, up 0.5% Y/Y, beating the consensus of $7.63 billion with 0.8% growth organic sales. Adjusted EPS was $2.39 compared to $1.97 in the prior-year quarter, beating the consensus of $2.10.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares shot up 64% to $0.3862 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>Shares of GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) got a boost, surging 47% to $16.17 after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares were also up, gaining 49% to $1.3850 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares dropped 27% to $5.25 after the company reported first-quarter financial results. Also, Piper Sandler reiterated an Underweight rating on the stock and lowered its price target from $8.5 to $6.</li>
<li>Shares of NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) were down 25% to $2.6501 after the company announced findings from its Phase 2b/3 trial of NRX-101 vs. Lurasidone.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) was down, falling 21% to $27.98 after the company reported mixed first-quarter financial results.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/04/38518458/dominos-pizza-to-rally-over-10-here-are-10-top-analyst-forecasts-for-tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
Commodities In commodity news, oil traded down 0.7% to $82.08 while gold traded down 2.2% at $2,306.60.
Silver traded down 3.7% to $26.645 on Tuesday, while copper fell 2.5% to $4.5590.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.68%, London's FTSE 100 fell 0.04% while Spain's IBEX 35 Index fell 2.22% The German DAX fell 1.03% French CAC 40 fell 0.99% while Italy's FTSE MIB Index fell 1.60%.
The annual inflation rate in the eurozone remained at 2.4% in April, in line with market estimates, while annual inflation rate in Italy slowed to 0.9% in April from 1.2% in the prior month. The annual inflation rate in France slowed to 2.2% in April from 2.3% in March, while producer prices in France declined 0.2% month-over-month in March. The French economy expanded by 0.2% quarter-over-quarter in the first quarter.
Consumer credit in the UK increased by £1.577 billion in March versus a revised £1.429 billion in the previous month. German economy grew by 0.2% in the first quarter following a 0.5% contraction in the prior period, while jobless rate in Germany remained at 5.9%for the fifth straight month in April. German retail sales rose by 1.8% month-over-month during March.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 adding 1.24%, Hong Kong's Hang Seng Index gaining 0.09%, China's Shanghai Composite falling 0.26% and India's S&amp;P BSE Sensex falling 0.25%.
Japan&#8217;s housing starts fell by 12.8% year-over-year in March following an 8.2% decline in the previous month. Retail sales in Japan climbed 1.2% year-over-year in March, while industrial production in rose 3.8% month-over-month in March.
The Caixin China General Manufacturing PMI rose to 51.4 in April versus 51.1 a month ago, while official NBS Manufacturing PMI declined to 50.4 in April from 50.8 in March.
Economics
<ul>
<li>The Chicago Business Barometer fell to 37.9 in April from 41.4 in the previous month.</li>
<li>The FHFA house price index rose 1.2% in February.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose by 7.3% year-over-year in February.</li>
<li>Compensation costs for civilian workers climbed by 1.2% during the first quarter.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38520037/jim-cramer-rejects-illumina-as-its-not-well-run-recommends-buying-this-tech-stock-right-here-right-n">Jim Cramer Rejects Illumina As &#8216;It&#8217;s Not Well-Run,&#8217; Recommends Buying This Tech Stock &#8216;Right Here, Right Now&#8217;</a>

Eurozone

Commodities

Intraday Update

AKLI

CHGG

NRXP

Gold Down Over 2%; 3M Profit Beats Expectations

Shares of H&amp;E Equipment Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) fell sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/HES/earnings">mixed first-quarter results</a>.
H&amp;E Equipment posted GAAP earnings of 71 cents per share, versus market estimates of 77 cents per share. The company's quarterly sales came in at $371.357 million versus expectations of $352.518 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
H&amp;E Equipment Services shares dipped 18.2% to $48.45 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares jumped 67.2% to $0.3927 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) gained 57.5% to $3.70 after the company highlighted plans for its previously-announced merger with Triller.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) climbed 55.4% to $2.12 after falling over 9% on Monday.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares gained 50.2% to $1.40 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) rose 40.8% to $15.49 after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) gained 39.4% to $7.00.</li>
<li>Swvl Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWVL#NASDAQ">SWVL</a>) surged 29.8% to $13.14 after announcing results for the fiscal year 2023.</li>
<li>Next.e.GO N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGOX#NASDAQ">EGOX</a>) gained 26.4% to $0.0349.</li>
<li>Blend Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares climbed 25.8% to $2.83 after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.</li>
<li>Daré Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) rose 24.2% to $0.3460 after the XOMA acquired an economic interest in the company&#8217;s women&#8217;s health assets. Also, the company announced that the transaction allows it to focus on advancing Phase 3 first-in-category women&#8217;s health product candidates.</li>
<li>LendingTree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) gained 24.2% to $46.39 after the company beat first-quarter estimates and issued strong guidance.</li>
<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) rose 24% to $5.85 following quarterly results.</li>
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) gained 19.8% to $6.85.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) rose 19.2% to $11.19 following a first-quarter revenue beat.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) rose 18.8% to $3.1002 after the company announced the launch of its AI-powered Anomaly Detector.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) gained 15.5% to $59.94 following upbeat quarterly results.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) gained 15.2% to $46.88 following better-than-expected earnings.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose 13.4% to $9.32 following strong quarterly earnings.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 13.3% to $1.53.</li>
<li>E2open Parent Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) rose 12.5% to $4.7950 following upbeat results.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) shares climbed 12.1% to $40.04 as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) jumped 10.3% to $8.31. Addex shares dipped 53% on Monday after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.</li>
<li>AgEagle Aerial Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#NASDAQ">UAVS</a>) gained 10.4% to $0.77. AgEagle announced $3.4 million drone sale to French Army.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) rose 9.2% to $108.28 after the company reported better-than-expected first quarter earnings and issued strong guidance.</li>
<li>Brinker International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) gained 7.5% to $53.38 after the company reported strong third-quarter financial results and raised FY24 guidance.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 6.6% to $785.51 after the company raised its FY24 revenue guidance.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) gained 5.5% to $97.25 following a first-quarter earnings beat.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 30.6% to $1.4127 after surging 48% on Monday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) declined 29.7% to $1.25.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares fell 26.1% to $5.30 after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) dipped 25% to $2.6592 after the company announced findings from its Phase 2b/3 trial of NRX-101 vs. Lurasidone.</li>
<li>Bakkt Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) fell 23.5% to $7.62. Bakkt Holdings is expected to release its first quarter 2024 earnings on Tuesday, May 14.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) shares declined 22.6% to $27.50 after the company reported mixed first-quarter financial results.</li>
<li>Vince Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) were down 21.4% to $1.6536 after the company posted fourth-quarter results.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) fell 20.1% to $1.63.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) dipped 18% to $1.14.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) declined 16.4% to $1,081.53 after the company reported worse-than-expected financial results for the first quarter.</li>
<li>Safe &amp; Green Holdings Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 16% to $0.1185 after declining 4% on Monday.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) declined 15.8% to $108.96 after the company reported worse-than-expected first quarter adjusted EPS results.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) fell 15% to $21.59 after the company reported worse-than-expected first-quarter sales results.</li>
<li>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) declined 13.2% to $77.22 following a first-quarter earnings miss.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares declined 13.1% to $10.34 after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 12.5% to $0.6393. Complete Solaria shares jumped 92% on Monday after the company named T.J. Rodgers as CEO.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) fell 11% to $5.18 after the company reported worse-than-expected quarterly sales results.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) declined 9.3% to $7.39 on reports NBCUniversal is preparing an offer that could take NBA rights from TNT.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) fell 7.6% to $168.36. F5 reported upbeat earnings for its second quarter, but issued weak forecast for the third quarter.</li>
<li>Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) declined 7.5% to $58.80 following quarterly results.</li>
<li>The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) fell 7.4% to $14.82 following quarterly earnings.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares declined 7.3% to $37.13. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares declined 7.3% to $56.10 following first-quarter results.</li>
</ul>
Now Read This: <a href="http://Domino's Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

Movers

ADXN

AGBA

ARCB

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLND

CECO

CETX

COUR

CSLR

CYCC

DARE

EGOX

ELYM

ETWO

FFIV

GEHC

HEES

HLIT

LICN

MIND

MRIN

MSTR

MULN

NIVF

RMBS

SGBX

SWVL

TREE

UAVS

VNCE

YUMC

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) with a Neutral and lowers the price target from $40 to $25.

DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $25

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday.
The Dow traded down 0.81% to 38,073.65 while the NASDAQ fell 0.80% to 15,855.75. The S&amp;P 500 also fell, dropping, 0.70% to 5,080.52.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38489087/jim-cramer-likes-palantir-recommends-pioneer-natural-resources-i-want-you-to-ka-ching-ka-ching"> Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: &#8216;I Want You To Ka-Ching, Ka-Ching&#8217;</a>
Leading and Lagging Sectors Health care shares rose by 0.1% on Tuesday.
In trading on Tuesday, energy shares fell by 1.6%.
Top Headline
Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) reported better-than-expected first-quarter results on Tuesday.
Coca-Cola reported first-quarter FY24 sales growth of 3% year-on-year to $11.3 billion, beating the analyst consensus estimate of $11.01 billion. Adjusted EPS of 72 cents beat the consensus estimate of 70 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares shot up 66% to $0.3956 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>Shares of AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) got a boost, surging 44% to $3.38 after the company highlighted plans for its previously-announced merger with Triller.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares were also up, gaining 54% to $1.43 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares dropped 26% to $5.34 after the company reported first-quarter financial results. Also, Piper Sandler reiterated an Underweight rating on the stock and lowered its price target from $8.5 to $6.</li>
<li>Shares of Vince Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) were down 24% to $1.60 after the company posted fourth-quarter results.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) was down, falling 23% to $27.41 after the company reported mixed first-quarter financial results.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/04/38518458/dominos-pizza-to-rally-over-10-here-are-10-top-analyst-forecasts-for-tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
Commodities In commodity news, oil traded down 0.9% to $81.88 while gold traded down 2.1% at $2,308.20.
Silver traded down 3.6% to $26.675 on Tuesday, while copper fell 2.5% to $4.5620.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.68%, London's FTSE 100 fell 0.04% while Spain's IBEX 35 Index fell 2.22% The German DAX fell 1.03% French CAC 40 fell 0.99% while Italy's FTSE MIB Index fell 1.60%.
The annual inflation rate in the eurozone remained at 2.4% in April, in line with market estimates, while annual inflation rate in Italy slowed to 0.9% in April from 1.2% in the prior month. The annual inflation rate in France slowed to 2.2% in April from 2.3% in March, while producer prices in France declined 0.2% month-over-month in March. The French economy expanded by 0.2% quarter-over-quarter in the first quarter.
Consumer credit in the UK increased by £1.577 billion in March versus a revised £1.429 billion in the previous month. German economy grew by 0.2% in the first quarter following a 0.5% contraction in the prior period, while jobless rate in Germany remained at 5.9%for the fifth straight month in April. German retail sales rose by 1.8% month-over-month during March.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 adding 1.24%, Hong Kong's Hang Seng Index gaining 0.09%, China's Shanghai Composite falling 0.26% and India's S&amp;P BSE Sensex falling 0.25%.
Japan&#8217;s housing starts fell by 12.8% year-over-year in March following an 8.2% decline in the previous month. Retail sales in Japan climbed 1.2% year-over-year in March, while industrial production in rose 3.8% month-over-month in March.
The Caixin China General Manufacturing PMI rose to 51.4 in April versus 51.1 a month ago, while official NBS Manufacturing PMI declined to 50.4 in April from 50.8 in March.
Economics
<ul>
<li>The Chicago Business Barometer fell to 37.9 in April from 41.4 in the previous month.</li>
<li>The FHFA house price index rose 1.2% in February.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose by 7.3% year-over-year in February.</li>
<li>Compensation costs for civilian workers climbed by 1.2% during the first quarter.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38520037/jim-cramer-rejects-illumina-as-its-not-well-run-recommends-buying-this-tech-stock-right-here-right-n">Jim Cramer Rejects Illumina As &#8216;It&#8217;s Not Well-Run,&#8217; Recommends Buying This Tech Stock &#8216;Right Here, Right Now&#8217; </a>

Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.59% to 38,159.97 while the NASDAQ fell 0.23% to 15,945.74. The S&amp;P 500 also fell, dropping, 0.23% to 5,104.26.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38489087/jim-cramer-likes-palantir-recommends-pioneer-natural-resources-i-want-you-to-ka-ching-ka-ching">Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: &#8216;I Want You To Ka-Ching, Ka-Ching&#8217;</a>
Leading and Lagging Sectors Health care shares rose by 0.5% on Tuesday.
In trading on Tuesday, materials shares fell by 0.7%.
Top Headline
McDonald's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) reported mixed first-quarter results on Tuesday.
McDonald's reported first-quarter FY24 sales growth of 4.6% year-on-year to $6.17 billion, beating the analyst consensus estimate of $6.155 billion. Adjusted EPS of $2.70 missed the consensus estimate of $2.72.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares shot up 64% to $0.3849 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>Shares of AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) got a boost, surging 61% to $3.78 after the company highlighted plans for its previously-announced merger with Triller.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares were also up, gaining 58% to $1.4650 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) shares dropped 27% to $1.4902.</li>
<li>Shares of Vince Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) were down 24% to $1.6090 after the company posted fourth-quarter results.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) was down, falling 22% to $27.71 after the company reported mixed first-quarter financial results.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/04/38518458/dominos-pizza-to-rally-over-10-here-are-10-top-analyst-forecasts-for-tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday </a>
Commodities In commodity news, oil traded up 0.3% to $82.91 while gold traded down 1.4% at $2,324.20.
Silver traded down 2.8% to $26.62 on Tuesday, while copper fell 1.3% to $4.6155.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.1%, London's FTSE 100 rose 0.5% while Spain's IBEX 35 Index fell 1.7% The German DAX fell 0.5% French CAC 40 fell 0.2% while Italy's FTSE MIB Index fell 0.5%.
The annual inflation rate in the eurozone remained at 2.4% in April, in line with market estimates, while annual inflation rate in Italy slowed to 0.9% in April from 1.2% in the prior month. The annual inflation rate in France slowed to 2.2% in April from 2.3% in March, while producer prices in France declined 0.2% month-over-month in March. The French economy expanded by 0.2% quarter-over-quarter in the first quarter.
Consumer credit in the UK increased by £1.577 billion in March versus a revised £1.429 billion in the previous month. German economy grew by 0.2% in the first quarter following a 0.5% contraction in the prior period, while jobless rate in Germany remained at 5.9%for the fifth straight month in April. German retail sales rose by 1.8% month-over-month during March.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 adding 1.24%, Hong Kong's Hang Seng Index gaining 0.09%, China's Shanghai Composite falling 0.26% and India's S&amp;P BSE Sensex falling 0.25%.
Japan&#8217;s housing starts fell by 12.8% year-over-year in March following an 8.2% decline in the previous month. Retail sales in Japan climbed 1.2% year-over-year in March, while industrial production in rose 3.8% month-over-month in March.
The Caixin China General Manufacturing PMI rose to 51.4 in April versus 51.1 a month ago, while official NBS Manufacturing PMI declined to 50.4 in April from 50.8 in March.
Economics
<ul>
<li>The Chicago Business Barometer fell to 37.9 in April from 41.4 in the previous month.</li>
<li>The FHFA house price index rose 1.2% in February.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose by 7.3% year-over-year in February.</li>
<li>Compensation costs for civilian workers climbed by 1.2% during the first quarter.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38520037/jim-cramer-rejects-illumina-as-its-not-well-run-recommends-buying-this-tech-stock-right-here-right-n&quot;">Jim Cramer Rejects Illumina As &#8216;It&#8217;s Not Well-Run,&#8217; Recommends Buying This Tech Stock &#8216;Right Here, Right Now&#8217;</a>

Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings

Shares of GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its <a href="https://www.benzinga.com/news/earnings/24/04/38505448/genedx-stock-climbs-after-better-than-expected-q1-results-raises-fy24-guidance">FY2024 sales guidance</a>.
GeneDx reported quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
GeneDx raised its full-year 2024 revenue guidance to between $235 million and $245 million, up from $220 million to $230 million, and expanded its full-year 2024 adjusted gross margin profile to at least 60% from at least 50%.
GeneDx Holdings shares climbed 37.4% to $15.11 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) gained 72.1% to $2.34 in pre-market trading after falling over 9% on Monday.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) gained 31% to $0.0851 in pre-market trading.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) rose 24.1% to $3.24 in today's pre-market trading after the company announced the launch of its AI-powered Anomaly Detector.</li>
<li>Blend Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares gained 20% to $2.70 in pre-market trading after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) jumped 20% to $9.05 in pre-market trading. Addex shares dipped 53% on Monday after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.</li>
<li>Movano Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares gained 18.6% to $0.5461 in pre-market trading after declining over 5% on Monday.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) shares climbed 15.8% to $41.43 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.</li>
<li>Warrantee Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRNT#NASDAQ">WRNT</a>) shares rose 14.7% to $0.3199 in pre-market trading. Warrantee shares fell over 6% on Monday after the company announced a receipt of a Nasdaq delising determination and a plan to appeal.</li>
<li>Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) shares gained 7.7% to $85.59 in pre-market trading following better-than-expected fourth-quarter results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 28.1% to $1.46 in pre-market trading after surging 48% on Monday.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) shares declined 15.6% to $29.95 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) fell 15.3% to $1.00 pre-market trading after declining 5% on Monday. iClick Interactive Asia recently announced the termination of its merger agreement.</li>
<li>Safe &amp; Green Holdings Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 14.9% to $0.12 in pre-market trading after declining 4% on Monday.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) shares fell 14.2% to $0.6410 in pre-market trading after gaining 8% on Monday.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 13.7% to $0.6303 pre-market trading. Complete Solaria shares jumped 92% on Monday after the company named T.J. Rodgers as CEO.</li>
<li>BioSig Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares fell 13.4% to $1.16 in pre-market trading.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares declined 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) shares declined 12.3% to $2.43 in pre-market trading.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares fell 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38510122/coca-cola-amazon-and-3-stocks-to-watch-heading-into-tuesday">Coca-Cola, Amazon And 3 Stocks To Watch Heading Into Tuesday</a>

BSGM

GWAV

ICLK

ILAG

LOGI

MOVE

WRNT

ZAPP

Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket

Medifast shares are trading lower after the company reported mixed Q1 financial results.

U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday.
Shares of Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) fell sharply in today's pre-market trading after the company <a href="https://www.benzinga.com/quote/MED/earnings">reported mixed first-quarter financial results.</a>
Medifast posted adjusted earnings of 66 cents per share, missing market estimates of 78 cents per share. The company's quarterly sales came in at $174.739 million versus expectations of $168.900 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Medifast shares tumbled 15.6% to $29.95 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares dipped 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares declined 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
<li>ADC Therapeutics SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NASDAQ">ADCT</a>) fell 6.7% to $4.20 in pre-market trading. The company, earlier during the month, announced the completion of dose escalation in LOTIS-7, a Phase 1b open-label clinical trial evaluating ZYNLONTA in combination with glofitamab or mosunetuzumab in heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.</li>
<li>Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares declined 5.7% to $6.69 in pre-market trading.</li>
<li>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) shares fell 5.7% to $4.63 in pre-market trading.</li>
<li>Prudential plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) slipped 5.1% to $17.84 in pre-market trading. Prudential, last month, reported worse-than-expected FY 2023 revenues and earnings.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares declined 5.1% to $38.00 in pre-market trading. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.</li>
<li>Sibanye Stillwater Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) shares fell 5% to $4.82 in pre-market trading.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares declined 4.1% to $58.01 in pre-market trading following first-quarter results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38510121/investor-sentiment-improves-further-dow-jumps-over-100-points">Investor Sentiment Improves Further, Dow Jumps Over 100 Points</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

ADCT

MESO

SBSW

Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Medifast Says 2024 Will Be A Year Of Investment For Future Growth

Nature's Sunshine Products: Cheap, But Not Entirely Without A Reason To Be

Here are the major earnings after the close today

Reports Q3 revenue $140.163M vs $235.869M last year. "Medical innovation has transformed the weight loss industry, so at Medifast (MED) we're creat...

Medifast reports Q3 EPS 10c vs $2.12 last year

Medifast Non-GAAP EPS of $0.35, revenue of $140.16M

Medifast, Inc. 2024 Q3 - Results - Earnings Call Presentation

Medifast ( ($MED) ) just unveiled an announcement. Medifast, known for its OPTAVIA lifestyle solution, reported a significant 40.6% drop in third-q...

Medifast Faces Revenue Decline, Ends Credit Agreement

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Medifast ( ($MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) ...

Medifast Faces Revenue Decline Amid Strategic Adjustments

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With cash ...

Medifast upgraded to Neutral from Underperform at DA Davidson

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

ABCL

ALAB

ANDE

AOSL

APLE

AQST

ATUS

AZPN

BCOV

BWXT

CDNA

CENX

CLLS

COTY

CRGY

CRUS

CSTL

EGHT

FTLF

HDSN

HIMS

HOLX

ICHR

ILMN

INSP

ITUB

LSCC

METC

NATR

NTST

NVTS

OTTR

PARR

SKIN

Press Releases

Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024

Medifast Announces First Quarter 2024 Financial Results

Legal

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm

Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Medifast Named as One of The "Best Companies To Work For" by U.S. News & World Report

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024

Medifast Announces Second Quarter 2024 Financial Results

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Comments

Medifast

Notizie

Ultime notizie per Medifast (NYSE:MED) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO